Embleema

Embleema

Created using Figma
Created using Figma

Última actualización

31 oct. 2018

Su historial médico es inviolable y siempre está disponible gracias a las funciones de seguridad y distribución de datos de Blockchain. Usted elige qué proveedores pueden ver qué parte de su historial médico y sabe exactamente quién accedió a él y cuándo Su privacidad está completamente protegida de una manera compatible con HIPAA
Riesgo: muy alto
Private Sale
oct., 2018
mar., 2019
100% terminado
Fondos recaudados - sin datos
309
Gol 20 000 000.00 USD
Gorra 2 000 000.00 USD
Tapa dura 30 000 000.00 USD
past
  • 1 RWD
    =
    0.2 USD
Detalles del token
Corazón
RWD
Monedas aceptadas
ETH, BTC, BCH, FIAT
Detalles de la compañía
Nombre de la empresa registrada
Embleema Inc
País registrado
United States, France
Empresa Fundada
Jun 1, 2017
Detalles adicionales
MVP / Prototipo
Plataforma
Ethereum
KYC
Categorías
Salud

Acerca de Embleema

Creemos que la tecnología Blockchain es el estándar ideal que puede proporcionar a pacientes, profesionales de la salud, proveedores de seguros de salud y proveedores una visión compartida, integral, longitudinal y confiable del historial médico de un paciente. Cuando se conserva como un libro de transacciones, el historial médico del paciente es claramente accesible para todas las partes interesadas con la debida autorización del paciente, y se puede determinar la mejor opción de tratamiento.

PatientTruth & trade; es una solución de software basada en Cloud y Blockchain que se conecta a diferentes registros médicos del paciente en los diversos centros de servicios de salud, como hospitales, prácticas de atención primaria, centros de rehabilitación, hogares de ancianos y centros de atención de urgencia, y los encadena de forma coherente. historial médico integral y a prueba de manipulaciones. PatientTruth & trade; proporciona una vista holística del historial médico de un paciente entre proveedores y centros de atención.

Caracteristicas

Patients can:

• Register and sign-on through the Patient Dapp interface,

• Upload their health records in the Blockchain, • Visualize their patient record,

• Authorize the sharing of their identified patient record to providers,

• Expose and sell their health records in the Marketplace against RWE tokens,

• Visualize a full audit-trail on their patient record access and health records sold,

• Visualize a statement of his/her RWE transactions.

 

Providers can:

• Register and sign-on through the Provider Dapp interface,

• Visualize an identified patient record, with due consent from the patient,

• Perform a health record quality check, when requested by the health record data owner,

• Visualize a statement of his/her RWE transactions,

 

Care Centers and other Data Owners can:

• Register and sign-on through the Data Owner Dapp interface,

• Have their health records indexed into the Blockchain and linked to patients,

• Expose and sell their health records in the Marketplace against RWE tokens, with due consent from the patients,

• Visualize a statement of RWE transactions,

 

Pharma companies, Payers and other Data Buyers can:

• Register and sign-on through the Data Buyer Dapp interface,

• Expose their inclusion criteria for health record purchases,

• Browse a list of data owners which own health records matching their inclusion criteria,

• Select the data owners they wish to purchase health records from,

• Execute the purchase in RWE tokens with data owners,

• Visualize a statement of RWE transactions,

 

Pharma companies and authorities can:

• Register and sign-on through the Real-World Evidence Dapp interface,

• Pharma companies register health products on which they wish to share with authorities Real-World Evidence, and define the patient records they wish to share,

• Authorities can visualize the shared Real-World Evidence from Pharma companies.

We expect Version 2 to be HIPAA compliant (see “Embleema and Privacy Compliance section” below) for the U.S. users and GDPR compliant for the European users. Version 2 will include health records from U.S. patients. Version 2 is planned to launch in Q3 2019.

Información técnica

Embleema Health Blockchain versión 2 contiene las siguientes funciones:


& bull; Contratos inteligentes específicos para el cuidado de la salud que gestionan el consentimiento del paciente,
almacenamiento de registros de salud, almacenamiento y uso compartido de registros de pacientes (identificados
y sin identificación), registro de auditoría de acceso de registros de pacientes y el Mercado
,
& bull; El token RWE incorporado generado por Blockchain para las tarifas de transacción
y otras recompensas. Las transacciones de tokens de RWE no requieren el pago de la tarifa "ldquo; gas & rdquo;
del remitente y tienen un tiempo de minería predecible,
& bull; API y analizadores de registros de salud para integrar en el Blockchain
varias entradas de formato de datos para registros de salud como HL 7 FHIR,
CCD, formatos de dispositivos conectados propietarios y otro formato de registro de salud,
& bull; Escalabilidad: hasta 2 millones de pacientes para el mercado estadounidense,
& bull; Rendimiento: la visualización de los registros de salud debe ocurrir en
2 segundos, la extracción en Blockchain debe ocurrir en menos de 5 segundos,
conciliar los compradores de datos con los criterios de inclusión de propietarios de datos
en el Mercado debe ocurrir en menos de 1 minuto , otro procesamiento por lotes
como el análisis de fuentes de datos e indexación se evaluará en términos de rendimiento para cada fuente de datos.

El contrato inteligente expuesto a los participantes de la red es:
& bull; Registro de salud: escriba, lea un registro de salud en Blockchain,
& bull; Registro del paciente: conecte los registros de salud a un paciente determinado, lea
el registro del paciente de Blockchain,
& bull; Consentimiento del paciente: define la autorización del paciente para compartir sus registros de salud
(identificados y anulados),
& bull; Registro de auditoría: proporciona a los propietarios de datos un seguimiento de auditoría sobre los accesos
a sus registros de salud,
y bull; Mercado: expone los metadatos de los registros de salud de los propietarios de los datos
luego de la debida autorización de los pacientes, permite a los compradores de datos buscar registros de salud para la compra, concuerda con los compradores de los datos y rsquo; criterios de inclusión
con registros de propietarios de datos, ejecuta transacciones de compra
entre compradores de datos y propietarios de datos,
& bull; Contrato inteligente de token de RWE: emite tokens de RWE como recompensas para los propietarios de datos
por almacenar registros de salud en la cadena de bloques (primeros 3 años)

Embleema Roadmap

  • Embleema’s growth plan

  • Embleema has already launched the first patient Blockchain.

    Version 1 is publicly accessible at https://patienttruth.embleema.com
    and contains the following functionalities:
    • Upload HL7 Continuity of Care Documents (CCD) medical records
    into blockchain by patients (U.S. patients only),
    • Upload of Fitbit information into blockchain by patients,
    • Consolidation of CCDs (U.S. patients only) and Fitbit information
    into a Medical history stored securely on blockchain,
    • Authorization management from patients for the sharing of their
    Medical history with providers,
    • Visualization by providers of patients’ Medical histories after due
    authorization from patients,
    • Audit-trail for patients of Medical history accesses by providers,
    • Compensation to patients in EBL tokens for uploading CCDs
    (U.S. patients only) and Fitbit information, as well as referrals of
    new patients and providers.

    Version 1 will be used to pilot and prove in real-life the relevance of
    the 2 key concepts carried by the Embleema Health Blockchain:
    • Patients have control of their health records and may share and
    sell their data to pharma companies: this pilot will start in September
    2018 with cysticfibrosis.com, a U.S. based patient community in
    Cystic Fibrosis (announced on July 17, 2018: https://medcitynews.
    com/2018/07/embleema-emerges-from-stealth-mode-launchesblockchain-
    based-health-record-system/),
    • Pharma companies and regulators share the next generation of
    RWE: real-time, individual-patient level 360 view medical histories,
    with continuous monitoring of the same patient and his/her full
    and trusted consent: this pilot will start in January 2019 with
    a top-5 global pharma company and a leading health regulator
    (announcement planned in Q4 2018).
  • End of 2019

  • End of 2019, Embleema expects to expand its Blockchain to the French
    market and the China marketplace with its 800 million connected patient
    population by striking a set of strategic distribution partnerships with major
    local players in the healthcare and technology industry.
  • Q3 2019

  • Concurrently to its V2 launch in Q3 2019, Embleema plans to set up consulting
    services for pharmaceuticals and health network to facilitate the
    adoption of blockchain in their processes and systems.
  • 2021

  • In 2021, Embleema plans to launch V3 of its Health Blockchain Network
    which will able to integrate mining nodes from pharma companies, payers
    and care centers. V3 will also implement an API allowing third party patient
    app providers to connect to the Blockchain and offer personalized services
    to patients through the Blockchain.
  • Lee mas
  • 2022

  • For 2022, with a critical mass of patient records stored onto the Blockchain,
    Embleema plans to offer advanced analytics services for various purposes:
    population health, observational studies, safety studies. Embleema will also
    start researching the possibility of offering predictive medicine services
    based on the wealth of data stored in the Blockchain.

Actividad

Actividad:
36
VERY LOW
Mérito:
0
VERY LOW
Mensajes:
12
VERY LOW
Puntos de vista:
558
VERY LOW
Usuarios:
7
VERY LOW
Seguidores:
2 325
MEDIUM
Tweets:
556
VERY HIGH
Crecimiento de 30 días:
-7

Embleema Equipo

Verificado 100%

Robert Chu
Founder, CEO and CTO
verificado
Prashant Khambekar,...
Chief Blockchain Development Executive
verificado
Pradeep Sreekanthan
Chief Delivery Officer
verificado
Vincent Galand
Manager, Operations
verificado
Pascal Becache
Business Development Executive
verificado
Nicolas Schmidt
Chief Product Officer
verificado
Alexis Normand
Head of Blockchain Consortium
verificado

Asesores

Verificado 29%

Atención. Existe el riesgo de que los miembros no verificados no sean realmente miembros del equipo

Vahan Simonyan, PhD
Advisor | Chief Scientist - WHISE-Embleema Health...
inconfirmado
Frederic Duchesne, P...
Advisor | CEO of Pierre Fabre Pharmaceuticals
inconfirmado
Atakan Seçkin
Advisor | User Experience
verificado
Pr. John Halamka, MD
Advisor | Professor of Innovation at Harvard Medic...
inconfirmado
Adel Al-Saleh
Advisor | CEO of T-Systems and Board Member of Deu...
inconfirmado
Bernard Gilly, PhD
Advisor | CEO at GenSight Biologics & Chairman at...
inconfirmado

2 ICO

$12 158 963

Lorenzo Nardiello
Social Media Manager
verificado

Embleema Entrevistas

Atakan Seçkin
As a team member, сan you tell us about your role in the ICO project?
Branding, UI/UX design and implementation of PatientTruth (since POC to product launch) ICO dashboard and future projects
What do you think about idea?
I've designed several products in healthcare industry prior to this project, and none of those projects placed the patient in the center - information asymmetry is a real problem. I believe blockchain with thoughtful design can enable patients to do so much more with their data - not only in terms of being aware, but also the control to choose who can see your data, and monetize it on your own terms and no one else's. We know we have a long road ahead, but I have confidence that we have the best team in the world to be making this product, and we can evolve it in a way that will disrupt existing industries.
Lorenzo Nardiello
As a team member, сan you tell us about your role in the ICO project?
I am in charge of the social media : Telegram, Bitcointalk, Reddit, Discord ... I also organize the bounty program that will come soon and manage our ambassador.
What do you think about idea?
Imagine a world in which you can contribute to medical research and create safer, less expensive and faster new treatments against cancer and rares diseases. Imagine a tamper-proof, holistic, longitudinal and patient-centric worldwide health record interfacing with medical researchers, health regulators, physicians, care centers and the pharmaceutical industry.
Robert Chu
As a team member, сan you tell us about your role in the ICO project?
Founder and CEO of Embleema
I am responsible for overall product strategy, go-to-market and sales of our Embleema Health Blockchain which was launched publicly in July 2018
What do you think about idea?
Embleema Health Blockchain helps patients to advance clinical research by securely sharing their data to pharmaceutical companies during real-world evidence and clinical trial studies. Pharmaceutical companies benefit from faster and more precise data which they can in turn share with regulators such as the U.S. Food and Drug Administration (FDA). Ultimately, patients receive innovative treatments sooner, this is the meaning of our work.
Prashant Khambekar, PhD
As a team member, сan you tell us about your role in the ICO project?
I handle the blockchain development. This includes the ICO/token part.

I also help determine the strategy of the company and its products.
What do you think about idea?
It is a wonderful idea whose time has come. Patients should have the right to control their own health data. The token mechanism helps maintain third-party oversight into the Embleema products.
Pradeep Sreekanthan
As a team member, сan you tell us about your role in the ICO project?
Delivering different versions of the platform. Making the customer experience delightful and easy. Working with various teams.
What do you think about idea?
Revolutionary - bringing healthcare to the blockchain is unusual and will be quite disruptive. RWE in particular.
Vincent Galand
As a team member, сan you tell us about your role in the ICO project?
I am Ops Manager at Embleema Inc. and run Embleema’s ICO operations, coordinating the team of technical experts, legal advisors, social media marketing manager and contractors around the project. I am also developping the business in Europe with pharma companies.
What do you think about idea?
I believe blockchain’s decentralisation power will disrupt the healthcare industry allowing everyone to participate to the advancement of medical progresses. Moreover, we developped a real, concrete industrial use case of Blockchain technology to accelerate medical research, e.g. Real World Evidence / Phase IV clinical trials. We are the only ICO project with a product already available on the market (PatientTruth), first major clients (Pierre Fabre, Servier, others coming soon) and a full support from the medical research community, the pharmaceutical industry and patient associations.
Pascal Becache
As a team member, сan you tell us about your role in the ICO project?
In France and Europe : Investors relations, business development, relations with Pharma companies. As a former IBM and IMS Health executive, I unveil the value of the patient data blockchain for investors, pharmaceutical companies, public and private health insurances and regulators.
What do you think about idea?
Embleema is the future of medical, drugs and population health studies. It will disintermediate collection and use of health data, allowing more, faster, cheaper and more ethical and transparent research benefiting to patients and healthcare systems. It complies with all regulatory aspects in the countries they enter.
Nicolas Schmidt
As a team member, сan you tell us about your role in the ICO project?
I'm Chief Product Officer at Embleema: I lead of our next product development, translate users and customers' needs into a world-class product and manage our marketing.
What do you think about idea?
We're the only healthcare project with a blockchain solution in production, valuable data on usage, several pharma companies as customers and a team of world-class advisors. We achieved all of this before launching our ICO in order to reduce risks for potential subscribers.
Alexis Normand
As a team member, сan you tell us about your role in the ICO project?
I bring together patient advocacy groups & life sciences researchers and regulatoirs to create a decentralized marketplace for health data, to replace the slow, manual and costly process of collecting real world evidence (RWE) for late stage clinical research
What do you think about idea?
Allowing patients to opt-in to pharma research along their own terms is game changing. Only blockchain allows patients to assemble the full picture of their health data, own and share it, and be compensated for their active involvement in clinical research.
  • Debido a que puede haber diferencias de tiempo en las actualizaciones de información, la información precisa sobre cada proyecto ICO debe verificarse a través de su sitio web oficial u otros canales de comunicación.
  • Esta información no es una sugerencia o consejo para invertir en fondos de la OIC. Por favor, investigue a fondo la información relevante y decida la participación de la OIC.
  • Si cree que hay problemas o correcciones a corregir en este contenido, o si desea enviar su propio proyecto ICO para que aparezca en la lista, por favor envíenos un correo electrónico.
Lea la exención de responsabilidad y la advertencia de riesgo. Mostrar descargo de responsabilidad y advertencia de riesgo.